Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (46)

2022

  1. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

2014

  1. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth

    Journal of Immunology, Vol. 192, Núm. 7, pp. 2939-2952

2010

  1. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis

    Gut, Vol. 59, Núm. 7, pp. 943-952

2009

  1. Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis

    Cancer Immunology, Immunotherapy, Vol. 58, Núm. 2, pp. 235-245

  2. Testicular cancer

    Medicine, Vol. 10, Núm. 27, pp. 1807-1816

2007

  1. Retrospective review in patients with pulmonary metastases of renal cell carcinoma receiving inhaled recombinant interleukin-2

    Anti-Cancer Drugs, Vol. 18, Núm. 3, pp. 291-296

2006

  1. Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis

    Journal of Clinical Immunology, Vol. 26, Núm. 2, pp. 101-112

2003

  1. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement

    Hepatology, Vol. 37, Núm. 1, pp. 208-217

  2. Inflammatory disease in urology. Standardization

    Actas Urologicas Espanolas, Vol. 27, Núm. 3, pp. 173-179

1999

  1. Factors mediating the hemodynamic effects of tumor necrosis factor-α in portal hypertensive rats

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 276, Núm. 3 39-3

  2. Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-α-2b and IL-2

    Journal of Immunotherapy, Vol. 22, Núm. 3, pp. 260-267

  3. Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis

    Digestive Diseases and Sciences, Vol. 44, Núm. 12, pp. 2530-2537

  4. The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients

    British Journal of Cancer, Vol. 79, Núm. 7-8, pp. 1162-1167

1998

  1. Evaluacion de los efectos hemodinamicos del factor de necrosis tumoral alfa en ratas con hipertension portal mediante la tecnica de las microesferas radiactivas

    Revista Espanola de Medicina Nuclear, Vol. 17, Núm. 4, pp. 294-301

  2. Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin a-induced hypertension

    Hepatology, Vol. 27, Núm. 2, pp. 332-338

1997

  1. Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladder

    British Journal of Cancer, Vol. 75, Núm. 12, pp. 1849-1853

  2. Urinary excretion of cytokines in bladder carcinoma

    Actas urologicas españolas, Vol. 21, Núm. 5, pp. 453-458

1995

  1. Alpha interferon as an immunomodulator in the treatment of patients with tumors

    Medical Oncology, Vol. 12, Núm. 1, pp. 15-21

  2. Functional defect of T cells in autoimmune gastritis

    Gut, Vol. 36, Núm. 2, pp. 171-175

  3. Use of intracavitary lnterferon‐alpha‐2b in the prophylactic treatment of patients with superficial bladder cancer

    Cancer, Vol. 75, Núm. 11, pp. 2720-2726